Investigation into the misincorporation of norleucine into a recombinant protein vaccine candidate

Journal of Industrial Microbiology and Biotechnology

Volumn 42, Issue 6, 2015, Pages 971-975

  Ni, Joyce ^a   Gao, Meg ^a   James, Andrew ^b   Yao, Jiansheng ^a   Yuan, Tao ^a   Carpick, Bruce ^b   D’Amore, Tony ^a   Farrell, Patrick ^a  

^a Bioprocess Research and Development   (Canada)

^b Sanofi Pasteur   (Canada)

Author keywords

Chemically defined medium (CDM); Misincorporation; Norleucine (Nle); Norvaline (Nva); Semi defined medium (SDM)

Indexed keywords

CULTURE MEDIUM; METHIONINE; NORLEUCINE; NORVALINE; RECOMBINANT PROTEIN; VACCINE; VALINE;

ANALOGS AND DERIVATIVES; BATCH CELL CULTURE; BIOSYNTHESIS; CHEMISTRY; CULTURE MEDIUM; DRUG EFFECTS; ESCHERICHIA COLI; FERMENTATION; GENETICS; IMMUNOLOGY; METABOLISM; PHARMACOLOGY;

BATCH CELL CULTURE TECHNIQUES; CULTURE MEDIA; ESCHERICHIA COLI; FERMENTATION; METHIONINE; NORLEUCINE; RECOMBINANT PROTEINS; VACCINES; VALINE;

EID: 84937761724     PISSN: 13675435     EISSN: 14765535     Source Type: Journal    
DOI: 10.1007/s10295-015-1613-x     Document Type: Article

References (21)

1. Abu-Absi N, Inlow, D, Macdonald AC, Poulhzan M (2008) Preventing norvaline and norleucine misincorporation in recombinant proteins. US Patent Application WO 2007/103521 A3
2. Apostol I, Levine J, Lippincott J, Leach J, Hess E, Glascock CB, Weickert MJ, Blackmore R (1997) Incorporation of norvaline at leucine positions in recombinant human hemoglobin expressed in Escherichia coli. J Biol Chem 272:28980–28988. doi:10.1074/jbc.272.46.28980
3. Baker DG, Bruton CJ (1979) The fate of norleucine as a replacement for methionine in protein synthesis. J Mol Biol 133:217–231. doi:10.1016/0022-2836(79)90531-X
4. Baneyx F (1999) Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol 10(5):411–421. doi:10.1016/S0958-1669(99)00003-8
5. Biermann M, Linnemann J, Knüpfer U, Vollsädt S, Bardl B, Seidel G, Horn U (2013) Trace element associated reduction of norleucine and norvaline accumulation during oxygen limitation in a recombinant Escherichia coli fermentation. Microb Cell Fact 12:116. doi:10.1186/1475-2859-12-116
6. Bogosian G, O’Neil JP, Smith HQ (2013) Prevention of incorporation of non-standard amino acids into proteins. US Patent 8,603,781
7. Bogosian G, Violand BN, Dorward-King EJ, Workman WE, Jung PE, Kane JF (1989) Biosynthesis and incorporation into protein of norleucine by Escherichia coli. J Biol Chem 264:531–539
8. Browth J (1973) The modification of the amino terminal region of Escherichia coli protein after initiation with methionine analogs. Biochim Biophys Acta 294:527–529
9. Fenton D, Lai PH, Lu H, Mann M, Tsai L (1994) Control of norleucine incorporation into recombinant proteins. US Patent 5,599,690
10. Kisumi M, Sugiura M, Chibata I (1975) Biosynthesis of norvaline, norleucine, and homoisoleucine in Serratia marcescens. J Biochem 80(2):333–339
11. Korz DJ, Rinas U, Hellmuth K, Sanders EA, Deckwer WD (1995) Simple fed-batch technique for high cell density cultivation of Escherichia coli. J Biotech 39:59–65. doi:10.1016/0168-1656(94)00143-Z
12. Lee SY (1996) High cell-density culture of Escherichia coli. Trends Biotechnol 14:98–105
13. Lu HS, Tsai LB, Kenney WC, Lai PH (1988) Identification of unusual replacement of methionine by norleucine in recombinant interleukin-2 produced by E. coli. Biochem Biophys Res Commun 156:807–813
14. Muramatsu R, Misawa S, Hayashi H (2003) Finding of an isoleucine derivative of a recombinant protein for pharmaceutical use. J Pharm Biomed Anal 31:979–987. doi:10.1016/S0731-7085(02)00703-3
15. Muramatsu R, Negishi T, Mimoto T, Miura A, Misawa S, Hayshi H (2002) Existence of beta-methylnorleucine in recombinant hirudin produced by Escherichia coli. J Biotechnol 93:131–142. doi:10.1016/S0168-1656(01)00396-0
16. Randhawa ZI, Witkowska HE, Cone J, Wilkins JA, Hughes P, Yamanishi K, Yasuda S, Masui Y, Arthur P, Kletke C (1994) Incorporation of norleucine at met positions in recombinant human macrophage colony stimulating factor (M-CSF, 4–153) expressed in Escherichia coli: structural analysis. Biochemistry 33:4352–4362
17. Soini J, Falschlehner C, Liedert C, Bernhardt J, Vuoristo J, Neubauer P (2008) Norvaline is accumulated after a down-shift of oxygen in Escherichia coli W3110. Microb Cell Fact 7:30. doi:10.1186/1475-2859-7-30
18. Sunasara KM, Cramer SM, Hauer CR, Rupp RG, Shoup VA (1999) Characterization of recombinant human brain-derived neurotrophic factor variants. Arch Biochem Biophys 372:248–260
19. Swartz JR (2001) Advances in Escherichia coli production of therapeutic proteins. Curr Opin Biotechnol 12(2):195–201
20. Tsai LB, Lu HS, Kenny WC, Curless CC, Klein ML, Lai PH, Fenton DM, Altrock BW, Mann MB (1988) Control of misincorporation of de novo synthesized norleucine into recombinant interleukin-2 in E. coli. Biophys Res Commun 156:733–739
21. Veeravalli K, Laird MW, Fedesco M, Zhang Y, Yu C (2014) Strain engineering to prevent Norleucine incorporation during recombinant protein production in Escherichia coli. Biotechnol Prog 31(1):204–211. doi:10.1002/btpr.1999